MGMT
6 abstracts
Abstract
Prognostic evaluation of surgical re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.Org: Department of Neurosurgery, University of Texas, Houston, TX, Department of Neurosurgery, University of Cologne, Cologne, Germany, Division for Neuro-Oncology, Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy, Division of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy, Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany,
Abstract
INB-200 phase I study of gene modified autologous gamma-delta (γδ) T cells in patients with newly diagnosed glioblastoma multiforme (GBM) receiving maintenance temozolomide (TMZ).Org: In8bio, University of Alabama at Birmingham Comprehensive Cancer Center, In8bio, Inc, In8Bio, Inc.,
Abstract
Investigation of leptomeningeal disease in high grade glioma and characterization of molecular alterations.Org: Caris Life Sciences, Irving, TX, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Levine Cancer Institute,
Abstract
Distinct molecular features and potential therapeutic strategies for spinal cord gliomas.Org: Caris Life Sciences, Irving, TX, Penn State Milton S. Hershey Medical Center, Hershey, PA, Levine Cancer Institute, West Virginia University Camden Clark Medical Center, Duke University Medical Center,
Abstract
Evolution of genomic profiles in primary and recurrent brain gliomas.Org: Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, Center of Oncocytogenomics, Intitute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague 2, Czech Republic, Center of Oncocytogenomics, Institute of medical Biochemistry and Laboratory Diagnostics,General University Hospital and 1st Faculty of Medicine, Charles Unive, Prague, Czech Republic, Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Charles Unive, Praha 2, Czech Republic, Institute of Hematology and Blood Transfusion, Prague, Czech Republic, Department of Neurosurgery and Neurooncology, First Faculty of Medicine of Charles University and Military University Hospital Prague, Prague, Czech Republic,
Abstract
Next generation sequencing reveals targetable mutations in multiple sarcoma histologies.Org: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Vanderbilt University School of Medicine, Vander Ingram Cancer Center, Division of Epidemiology and Community Health,